- From: Giovanna Sannino <giovanna.sannino@icar.cnr.it>
- Date: Thu, 12 Nov 2026 09:11:23 +0100
- To: semantic-web@w3.org
- Message-ID: <5b5fd352-85d6-433d-b39a-d2e8afc1e598@icar.cnr.it>
Dear colleagues,
We are pleased to invite you to submit your research contributions to
IEEE SBiND 2027, the ICASSP 2027 Satellite Workshop on Speech Biomarkers
for Neurodegenerative Diseases: Signal Processing, Artificial
Intelligence, and Clinical Translation.
The paper submission deadline has been extended to November 30, 2026!
The SBiND 2027 Best Paper Award, sponsored by MAKE journal, includes a
CHF 200 prize. The winning authors will also be invited to submit a
substantially extended version of their paper to the planned SBiND
Special Issue in MAKE, with a full APC waiver if the manuscript is
accepted for publication.
Additionally, authors of other selected high-quality workshop papers
will also be invited to submit substantially extended and enhanced
versions of their contributions to the Special Issue.
We warmly welcome contributions from researchers, clinicians, engineers,
and practitioners working at the intersection of speech and signal
processing, artificial intelligence, neurology, clinical neuroscience,
biomedical engineering, and digital health.
SBiND 2027 will take place on May 17, 2027, in Toronto, Canada, in
conjunction with the 2027 IEEE International Conference on Acoustics,
Speech, and Signal Processing (ICASSP 2027).
Kind regards,
The SBiND 2027 Organizing Committee
===============================================================
SBiND 2027
Speech Biomarkers for Neurodegenerative Diseases: Signal Processing,
Artificial Intelligence, and Clinical Translation
May 17, 2027 – Toronto, Canada
https://www.sbind.icar.cnr.it/
Satellite Workshop of the 2027 IEEE International Conference on
Acoustics, Speech, and Signal Processing – ICASSP 2027
Submit your paper:
https://cmsworkshops.com/ICASSP2027/papers/submission.asp?ID=7&Type=WS
===============================================================
MISSION:
Neurodegenerative diseases such as Amyotrophic Lateral Sclerosis,
Parkinson’s disease, and Alzheimer’s disease progressively affect speech
production through changes in motor control, cognition, language, and
respiratory function. Speech and voice therefore represent promising
non-invasive and easily accessible biomarkers for supporting disease
assessment, monitoring progression, and evaluating treatment response.
SBiND 2027 aims to bring together researchers, clinicians, engineers,
and industry professionals working on speech and voice biomarkers for
neurodegenerative diseases. The workshop will promote interdisciplinary
discussion on the development of reliable signal-processing and
artificial-intelligence methods and their translation into clinically
meaningful and deployable solutions.
Building on previous research and challenge-based initiatives in this
field, SBiND will address the methodological, clinical, and
technological barriers that currently limit the generalizability,
interpretability, reproducibility, and real-world adoption of
speech-based biomarkers.
The workshop will include contributed papers, invited talks, and a
multidisciplinary panel, providing a forum for sharing recent advances,
clinical perspectives, open challenges, and future research directions.
TOPICS:
Topics of interest include, but are not limited to:
• Speech and voice biomarkers for neurodegenerative diseases
• Speech signal processing for neurological assessment and monitoring
• Acoustic, phonetic, prosodic, linguistic, and conversational biomarkers
• Artificial intelligence and machine learning for speech-based assessment
• Deep learning, self-supervised learning, and foundation models
• Automatic detection, classification, and differential diagnosis
• Longitudinal modelling and disease-progression prediction
• Multilingual, cross-lingual, and cross-corpus generalization
• Domain adaptation and robust learning across recording conditions
• Explainable and clinically interpretable artificial intelligence
• Multimodal integration of speech, language, clinical, imaging, and
sensor data
• Digital phenotyping and remote patient monitoring
• Mobile, wearable, and telemedicine solutions for speech assessment
• Data quality, annotation protocols, and dataset harmonization
• Privacy-preserving learning and secure health-data processing
• Federated learning for distributed clinical data
• Bias, fairness, ethics, and responsible AI in clinical applications
• Reproducibility, benchmarking, and open science
• Clinical validation and real-world deployment
• Human-centred technologies and clinician–AI collaboration
• Regulatory and translational challenges for speech-based digital
biomarkers
IMPORTANT DATES:
• EXTENDED paper submission deadline: November 30, 2026 (previously
November 11, 2026)
• EXTENDED notification of paper acceptance: December 31, 2026
(previously December 16, 2026)
• Camera-ready paper submission: January 27, 2027
• Workshop date: May 17, 2027
PAPER SUBMISSION:
Authors are invited to submit original research contributions addressing
the workshop topics.
Submitted papers must follow the ICASSP 2027 paper style, formatting,
and length requirements. Papers may contain a maximum of four pages of
technical content, including figures and references, with an optional
fifth page containing references only.
Papers must be submitted through the official ICASSP 2027 Satellite
Workshop submission system:
https://cmsworkshops.com/ICASSP2027/papers/submission.asp?ID=7&Type=WS
All submissions will undergo a rigorous peer-review process managed
independently by the SBiND 2027 Technical Program Committee.
Accepted and presented papers will be published in the IEEE Xplore
Digital Library under a separate ICASSP 2027 Satellite Workshop record
number.
At least one author of each accepted paper must register for the
workshop and present the paper in person. Papers that are not presented
in accordance with the conference policies will be withdrawn from the
official proceedings.
BEST PAPER AWARD:
The SBiND 2027 Best Paper Award, sponsored by MAKE journal, includes a
CHF 200 prize and a certificate. The winning contribution will be
selected by the Workshop Chairs based on scientific significance,
originality, methodological quality, clinical relevance, and the
evaluations of the Technical Program Committee.
The winning authors will also be invited to submit a substantially
extended version of their paper to the planned SBiND Special Issue in
MAKE with a full APC waiver. The extended manuscript will undergo MAKE’s
standard independent peer-review and editorial process. The APC waiver
applies if the manuscript is accepted for publication.
SPECIAL ISSUE:
A dedicated SBiND Special Issue is planned in MAKE – Machine Learning
and Knowledge Extraction journal.
Authors of selected high-quality papers presented at the workshop will
be invited to submit substantially extended and enhanced versions of
their contributions. Extended submissions must include significant new
material beyond the workshop paper and will be treated as new journal
manuscripts.
An invitation to submit does not guarantee acceptance. All extended
manuscripts will undergo the journal’s standard independent peer-review
and editorial process. The Special Issue title, scope, deadlines, and
Guest Editor team will be announced soon.
CONTACT:
For further information, please visit: https://www.sbind.icar.cnr.it/
For questions, please contact: sbind@icar.cnr.it
--
Dr. Giovanna Sannino
Senior Researcher
Head of AI-ISA Research Group - www.ai-isa.icar.cnr.it
<https://www.ai-isa.icar.cnr.it>
Italian Science Fund (FIS) Grant Awardee
Institute for High-Performance Computing and Networking (ICAR)
National Research Council of Italy (CNR)
Via P. Castellino 111, 80131 Naples, Italy
Executive Editor of Biomedical Signal Processing and Control
Associate Editor of IEEE Transactions on Affective Computing
Associate Editor of Applied Soft Computing
Editor of Engineering Applications of Artificial Intelligence<
Connect with me on LinkedIn
<https://www.linkedin.com/in/giovannasannino/>
Received on Thursday, 12 November 2026 08:11:30 UTC